Johnson et al., 1974 - Google Patents
Detection of cells producing antibody to hepatitis B surface antigen by an indirect hemolytic plaque assayJohnson et al., 1974
- Document ID
- 4173710927244986310
- Author
- Johnson R
- Hoofnagle J
- Gerety R
- Barker L
- Merchant B
- Publication year
- Publication venue
- Intervirology
External Links
Snippet
Hemolytic plaque assays in gel were performed against burro red blood cells (BRBC) conjugated with hepatitis B surface antigen (HBS Ag). On indirect assay, spleen cells from HBS Ag-immunized mice gave 27–68 times more plaques than cells from unimmunized …
- 238000004166 bioassay 0 title abstract description 20
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ogburn et al. | Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose | |
Budkowska et al. | Hepatitis B virus pre-S gene-encoded antigenic specificity and anti-pre-S antibody: relationship between anti-pre-S response and recovery | |
JP2602517B2 (en) | Method for isolating novel viral factor derived from non-A non-B hepatitis and antigen bound thereto, viral factor and antigen obtained by this method, method for detecting this antigen, and immunoreagent for detecting non-A non-B viral hepatitis , Its manufacturing method and application | |
US5019386A (en) | Hepatitis B vaccine | |
KR930001278B1 (en) | Method for preparing monoclonal antibody against hepatitis B surface antigen (HBsAg) | |
CA1184846A (en) | Non-a, non-b hepatitis-associated antigen and diagnostic reagent | |
Okamoto et al. | Antibody to the receptor for polymerized human serum albumin in acute and persistent infection with hepatitis B virus | |
Takahashi et al. | Shift from free “small” hepatitis B e antigen to IgG-bound “large” form in the circulation of human beings and a chimpanzee acutely infected with hepatitis B virus | |
Gold et al. | Characterization of antibodies to the structural polypeptides of HBsAg: evidence for subtype-specific determinants | |
AU628156B2 (en) | Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis b viral envelope | |
EP0068465B1 (en) | Non-a, non-b hepatitis-associated antibody conjugate, the use thereof and detection reagent | |
Möller et al. | HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation | |
Steward et al. | Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions | |
Kennedy et al. | Characterization of anti-hepatitis B surface antigen monoclonal antibodies | |
JPS63157060A (en) | Test of antibody to b-type hepatitis core antigen | |
US4132767A (en) | Preparation of α-L antibody, purification of α-L antigen and reagent for detection of α-L antibody and α-L antigen | |
Johnson et al. | Detection of cells producing antibody to hepatitis B surface antigen by an indirect hemolytic plaque assay | |
Tabor et al. | Induction of Antibody to the “y” Determinant of HBsAg in a Chimpanzee Carrier of HBsAg Subtype “adw” | |
Rizzetto et al. | A radioimmunoassay for HBcAg in the sera of HBsAg carriers: Serum HBcAg, serum DNA polymerase activity, and liver HBcAg immunofluorescence as markers of chronic liver disease | |
EP0456215A1 (en) | Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis B viral envelope | |
EP0082789B1 (en) | Immunological composition and method for hepatitis b virus | |
US4778784A (en) | Cyclic peptide and method of use for inducing an immunological response to hepatitis B virus | |
Prince et al. | A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine | |
Petit et al. | Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles | |
CN115772217A (en) | HBV S protein specific monoclonal antibody HBV-S-4H7 and application thereof in preparation of detection kit |